1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Contraceptive Drugs and Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Vaginal
1.4.4 Injectable Contraceptive Drugs
1.4.5 Male/Female Contraceptive Devices
1.5 Market by Application
1.5.1 Global Contraceptive Drugs and Devices Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Contraceptive Drugs and Devices Market
1.8.1 Global Contraceptive Drugs and Devices Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Contraceptive Drugs and Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Contraceptive Drugs and Devices Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Contraceptive Drugs and Devices Sales Volume Market Share by Region (2015-2020)
3.2 Global Contraceptive Drugs and Devices Sales Revenue Market Share by Region (2015-2020)
3.3 North America Contraceptive Drugs and Devices Sales Volume
3.3.1 North America Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.3.2 North America Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Contraceptive Drugs and Devices Sales Volume
3.4.1 East Asia Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.5.1 Europe Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.6.1 South Asia Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.7.1 Southeast Asia Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.8.1 Middle East Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.9.1 Africa Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.10.1 Oceania Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.11.1 South America Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.11.2 South America Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Contraceptive Drugs and Devices Sales Volume (2015-2020)
3.12.1 Rest of the World Contraceptive Drugs and Devices Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Contraceptive Drugs and Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Contraceptive Drugs and Devices Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Contraceptive Drugs and Devices Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Contraceptive Drugs and Devices Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Contraceptive Drugs and Devices Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Contraceptive Drugs and Devices Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Contraceptive Drugs and Devices Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Contraceptive Drugs and Devices Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Contraceptive Drugs and Devices Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Contraceptive Drugs and Devices Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Contraceptive Drugs and Devices Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Contraceptive Drugs and Devices Sales Volume Market Share by Type (2015-2020)
14.2 Global Contraceptive Drugs and Devices Sales Revenue Market Share by Type (2015-2020)
14.3 Global Contraceptive Drugs and Devices Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Contraceptive Drugs and Devices Consumption Volume by Application (2015-2020)
15.2 Global Contraceptive Drugs and Devices Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Contraceptive Drugs and Devices Business
16.1 Bayer Healthcare
16.1.1 Bayer Healthcare Company Profile
16.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Specification
16.1.3 Bayer Healthcare Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Mayer Laboratories
16.2.1 Mayer Laboratories Company Profile
16.2.2 Mayer Laboratories Contraceptive Drugs and Devices Product Specification
16.2.3 Mayer Laboratories Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Warmer Chilcott
16.3.1 Warmer Chilcott Company Profile
16.3.2 Warmer Chilcott Contraceptive Drugs and Devices Product Specification
16.3.3 Warmer Chilcott Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Merck
16.4.1 Merck Company Profile
16.4.2 Merck Contraceptive Drugs and Devices Product Specification
16.4.3 Merck Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 BioSante Pharmaceuticals
16.5.1 BioSante Pharmaceuticals Company Profile
16.5.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Specification
16.5.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Church & Dwight
16.6.1 Church & Dwight Company Profile
16.6.2 Church & Dwight Contraceptive Drugs and Devices Product Specification
16.6.3 Church & Dwight Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Teva Pharmaceutical Industries
16.7.1 Teva Pharmaceutical Industries Company Profile
16.7.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Specification
16.7.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Pfizer
16.8.1 Pfizer Company Profile
16.8.2 Pfizer Contraceptive Drugs and Devices Product Specification
16.8.3 Pfizer Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Agile Therapeutics
16.9.1 Agile Therapeutics Company Profile
16.9.2 Agile Therapeutics Contraceptive Drugs and Devices Product Specification
16.9.3 Agile Therapeutics Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Pantarhei Bioscience
16.10.1 Pantarhei Bioscience Company Profile
16.10.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Specification
16.10.3 Pantarhei Bioscience Contraceptive Drugs and Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Contraceptive Drugs and Devices Manufacturing Cost Analysis
17.1 Contraceptive Drugs and Devices Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices
17.4 Contraceptive Drugs and Devices Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Contraceptive Drugs and Devices Distributors List
18.3 Contraceptive Drugs and Devices Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Contraceptive Drugs and Devices (2021-2026)
20.2 Global Forecasted Revenue of Contraceptive Drugs and Devices (2021-2026)
20.3 Global Forecasted Price of Contraceptive Drugs and Devices (2015-2026)
20.4 Global Forecasted Production of Contraceptive Drugs and Devices by Region (2021-2026)
20.4.1 North America Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.3 Europe Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.7 Africa Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.9 South America Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Contraceptive Drugs and Devices Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Contraceptive Drugs and Devices by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.2 East Asia Market Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.3 Europe Market Forecasted Consumption of Contraceptive Drugs and Devices by Countriy
21.4 South Asia Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.5 Southeast Asia Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.6 Middle East Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.7 Africa Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.8 Oceania Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.9 South America Forecasted Consumption of Contraceptive Drugs and Devices by Country
21.10 Rest of the world Forecasted Consumption of Contraceptive Drugs and Devices by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer